Samrat Pharmachem Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 210 as of 18 May 14:00 . The P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 yearsThe P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 yearsThe Market Cap of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 14.94 crore on March 2025 to ₹ 14.94 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Samrat Pharmachem Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 63.83 crore. This represent the decline of -100% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 4.04 crore as compare to the Dec '25 revenue of ₹ 1.62 crore. This represent the growth of 149.38% The ebitda of Samrat Pharmachem Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the decline of -100% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.11 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the growth of 175% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0.11 crore over 8 quarters. This represents a CAGR of 231.66% The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Samrat Pharmachem Ltd is 64 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 29 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 18, 2026, the Samrat Pharmachem Ltd stock price is INR ₹209.5. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹25.3.

How do dividend payouts of Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.